Authors: Lippman, ME Krueger, KA Eckert, S Sashegyi, A Walls, EL Jamal, S Cauley, JA Cummings, SR

Citation: Me. Lippman et al., Indicators of lifetime estrogen exposure: Effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants, J CL ONCOL, 19(12), 2001, pp. 3111-3116

Authors: Cauley, JA Norton, L Lippman, ME Eckert, S Krueger, KA Purdie, DW Farrerons, J Karasik, A Mellstrom, D Ng, KW Stepan, JJ Powles, TJ Morrow, M Costa, A Silfen, SL Walls, EL Schmitt, H Muchmore, DB Jordan, VC

Citation: Ja. Cauley et al., Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial, BREAST CANC, 65(2), 2001, pp. 125-134

Authors: Cummings, SR Grady, D Black, D Eckert, S Krueger, KA Nickelsen, T Glusman, JE Powles, TJ Cauley, JA Norton, L Bjarnason, NH Morrow, M Jordan, VC Lippman, ME Costa, A

Citation: Sr. Cummings et al., Estrogen-receptor status in breast cancer - Reply, J AM MED A, 283(3), 2000, pp. 338-339

Authors: Cummings, SR Eckert, S Krueger, KA Grady, D Powles, TJ Cauley, JA Norton, L Nickelsen, T Bjarnason, NH Morrow, M Lippman, ME Black, D Glusman, JE Costa, A Jordan, VC

Citation: Sr. Cummings et al., The effect of raloxifene on risk of breast cancer in postmenopausal women - Results from the MORE randomized trial, J AM MED A, 281(23), 1999, pp. 2189-2197

Authors: Krueger, KA Ings, EI Brun, AM Landt, M Easom, RA

Citation: Ka. Krueger et al., Site-specific phosphorylation of synapsin I by Ca2+/calmodulin-dependent protein kinase II in pancreatic beta TC3 cells - Synapsin I is not associated with insulin secretory granules, DIABETES, 48(3), 1999, pp. 499-506